Share on StockTwits

AstraZeneca plc (NYSE:AZN)‘s stock had its “hold” rating reissued by stock analysts at Deutsche Bank in a report issued on Friday.

A number of other analysts have also recently weighed in on AZN. Analysts at Beaufort Securities reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Friday. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of AstraZeneca plc in a research note on Thursday, August 14th. Finally, analysts at Barclays reiterated an “equal weight” rating on shares of AstraZeneca plc in a research note on Monday, August 4th. Four analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $57.00.

Shares of AstraZeneca plc (NYSE:AZN) traded down 0.19% on Friday, hitting $73.05. The stock had a trading volume of 1,913,208 shares. AstraZeneca plc has a one year low of $48.53 and a one year high of $82.68. The stock’s 50-day moving average is $72.76 and its 200-day moving average is $70.62. The company has a market cap of $92.262 billion and a price-to-earnings ratio of 45.66. AstraZeneca plc also saw unusually large options trading on Thursday. Stock traders purchased 20,242 call options on the stock. This is an increase of approximately 544% compared to the average daily volume of 3,143 call options.

AstraZeneca plc (NYSE:AZN) last posted its quarterly earnings results on Thursday, July 31st. The company reported $1.30 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.09 by $0.21. The company had revenue of $6.45 billion for the quarter, compared to the consensus estimate of $6.24 billion. During the same quarter last year, the company posted $1.20 earnings per share. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, analysts predict that AstraZeneca plc will post $4.40 earnings per share for the current fiscal year.

The company also recently announced a semiannual dividend, which is scheduled for Monday, September 15th. Investors of record on Friday, August 15th will be paid a dividend of $0.90 per share. This represents a dividend yield of 2.48%. The ex-dividend date is Wednesday, August 13th.

AstraZeneca PLC (NYSE:AZN) is a global biopharmaceutical company.

Receive News & Ratings for AstraZeneca plc (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca plc (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.